FeesSafety
Pluang+

Bitcoin's NUPL score rises to 0.36, signaling strong potential gains based on historical trends.

Protocol Fundamentals
29 Oct 2026, 15:21 WIB
Tokenpost
View Source
Bullish
Bitcoin's NUPL score rises to 0.36, signaling strong potential gains based on historical trends.

Fidelity Digital Assets reported Bitcoin's Net Unrealized Profit/Loss (NUPL) score increased to 0.36 at the end of Q3 2026, up from 0.09 at the end of Q2. This metric measures holders' unrealized profits, and historically, when the score is near 0.36, Bitcoin has seen a median one-year return of 93%. Despite this positive indicator, Bitcoin's price was $80,015, down 1.11% over the past 24 hours as of the latest data. This suggests potential for strong future gains based on past performance, though short-term price fluctuations remain.

Fidelity Digital Assets' report on Bitcoin's NUPL at Q3 close provides context for market sentiment. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Oct 29, 2026 18:53 WIB: out of 50 major cryptocurrencies priced on Pluang, 7 rose and 42 fell today. Notable movers include EOS at Rp12.649 with an 8.13% increase, BAT at Rp2.531 down 6.25% but with 100% buy order activity, and BCH at Rp5.110.888 down 5.73% with a 58% buy order activity.

More News

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

NCH performs US first tricuspid valve repair with PASCAL Precision system after FDA approval

Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...

Market News
Bullish
1 hour ago
Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore to present Phase 1 data on brenetafusp and KIMMTRAK combo for metastatic uveal melanoma at SITC 2026

Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...

Company Fundamentals
Bullish
1 hour ago
Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC expand partnership to support neurodivergent youth in Massachusetts sports.

Collegium Pharmaceutical and Boston Legacy FC have extended their partnership to include youth coach training, an annual Sports for All Summit, and sensory inclusion programs aimed at supporting neurodivergent children, especially those with ADHD, in...

Others
Bullish
2 hours ago
Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks to attend Deutsche Bank Global Space and Defense Tech Summit in NYC

Gilat Satellite Networks announced that its CEO Adi Sfadia and CFO Gil Benyamini will attend the Deutsche Bank Global Space and Defense Tech Summit on November 18, 2026, in New York City. The event will feature one-on-one and group meetings, providin...

Market News
Neutral
2 hours ago
Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex buys Wind2 to boost UK wind energy projects by 350 MW, expanding its renewable footprint.

Boralex Inc. has acquired Wind2, a UK-based renewable energy developer with about 350 MW of advanced wind projects across Scotland, England, and Wales. This acquisition strengthens Boralex's presence and capabilities in the UK, aligning with its stra...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App